Evidence map›Paper›PMID 42005593›Full record

ArticleIJU case reports2026

Two Cases of Hereditary Paraganglioma-Pheochromocytoma Syndrome in Siblings, Caused by a Novel Succinate Dehydrogenase Complex Subunit D Variant.

Ryuto Nakamura, Yoshiyuki Yamamoto, Taigo Kato, Kosuke Mukai, Motonari Nomura, Satoshi Nojima, Koji Hatano, Yoichi Kakuta, Atsunari Kawashima, Norio Nonomura

Abstract read
In one paragraph

Article in IJU case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ryuto NakamuraDepartment of Urology The University of Osaka, Graduate School of Medicine Osaka Japan.
Yoshiyuki YamamotoDepartment of Urology The University of Osaka, Graduate School of Medicine Osaka Japan.ORCID https://orcid.org/0000-0002-1271-3521
Taigo KatoDepartment of Urology The University of Osaka, Graduate School of Medicine Osaka Japan.
Kosuke MukaiDepartment of Metabolic Medicine The University of Osaka, Graduate School of Medicine Osaka Japan.
Motonari NomuraDepartment of Pediatric Surgery The University of Osaka, Graduate School of Medicine Osaka Japan.
Satoshi NojimaDepartment of Pathology The University of Osaka, Graduate School of Medicine Osaka Japan.
Koji HatanoDepartment of Urology The University of Osaka, Graduate School of Medicine Osaka Japan.
Yoichi KakutaDepartment of Urology The University of Osaka, Graduate School of Medicine Osaka Japan.ORCID https://orcid.org/0000-0001-5339-4312
Atsunari KawashimaDepartment of Urology The University of Osaka, Graduate School of Medicine Osaka Japan.ORCID https://orcid.org/0000-0001-9369-4264
Norio NonomuraDepartment of Urology The University of Osaka, Graduate School of Medicine Osaka Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Pheochromocytomas and paragangliomas are increasingly recognized as hereditary malignancies, with ~30%-40% of cases involving germline variants. We report a familial case of hereditary pheochromocytoma-paraganglioma syndrome caused by a novel variant in the Case Presentation: An 11-year-old boy was diagnosed with retroperitoneal paraganglioma. Pathological analysis confirmed the resected tumor as a pheochromocytoma and paraganglioma. Conclusion: Early identification of hereditary risks associated with pheochromocytomas and paragangliomas facilitates appropriate lifelong surveillance, timely treatment decisions, and informed genetic counseling.

Indexed as

genetic counselinghereditary pheochromocytoma‐paraganglioma syndromeparagangliomapheochromocytomaSDHD

Identifiers

PMID42005593
PMCPMC13087517

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.